PD-L1 is expressed by immune cells under inflammatory conditions and by tumor cells as an “adaptive immune mechanism” to escape anti-tumor responses; it induces an inhibitory response to T cells by binding PD-1 expressed on T cells, generating immune tolerance toward tumor cells. This evidence concerns the gene CD274 and neoplasm.